return to small text site

 

US
Europe
US
Europe

press releases

press coverage
electronic press kit
LX211
LX201

LX214

LX212
polymer technology
pipeline
other projects

uveitis

corneal transplantation
dry eye syndrome

age-related macular degeneration

mission
history
management
board of directors
investors

About

Ophthalmic Indications
Products &
Technologies

Partners

News & Media
Careers
Contact Us

 

  Other Projects
 

Lux Biosciences has a series of additional earlier stage products targeting a range of ophthalmic diseases in which inflammation and the immune system contribute to the disease etiology. These projects will be announced at a later date. The earlier stage projects will be brought forward to the clinic rapidly supported by a strong emphasis on translational research.

 

© 2008 Lux Biosciences, Inc. All rights reserved.                 Web Terms